Myostatin-related muscle hypertrophy
Senast uppdaterad 2 Oct 2024
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Myostatin-related muscle hypertrophy is a rare condition characterised by reduced body fat and increased muscle size. Affected individuals have up to twice the usual amount of muscle mass in their bodies. They also tend to have increased muscle strength. Myostatin-related muscle hypertrophy is not known to cause any medical problems, and affected individuals are intellectually normal.
Videoval för Genetiska tillståndVideobibliotek
Beskrivning
Myostatin-related muscle hypertrophy is a rare condition characterised by reduced body fat and increased muscle size. Affected individuals have up to twice the usual amount of muscle mass in their bodies. They also tend to have increased muscle strength. Myostatin-related muscle hypertrophy is not known to cause any medical problems, and affected individuals are intellectually normal.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
Muscle hypertrophy syndrome
Related patient information and medicines

Patient information leaflet
Kan jag ta Atorvastatin och Pyridostigmin tillsammans?
There is a potential for increased muscle-related side effects when taking these two medicines together. Both drugs can independently affect muscle function; atorvastatin can cause muscle aches or weakness (myopathy), och pyridostigmine is used to treat muscle weakness in conditions like myasthenia gravis. Taking them together might make it harder.

Patient information leaflet
Muskeldystrofi
Muscular dystrophy is an inherited (genetic) disorder causing muscle weakness. There are different types of muscular dystrophy, which vary as to how severe they are, rangi... Muscular dystrophy (MD) is the name given to a group of disorders which cause progressive muscle weakness (meaning it gets worse over time). These are: Muscle wasting - in.

Patient information leaflet
Kan jag ta Atorvastatin och Prednisolon tillsammans?
Tar atorvastatin and prednisolone together may increase the risk of muscle-related side effects, såsom muscle pain, tenderness, or weakness. In rare cases, this can lead to a serious condition called rhabdomyolysis, where muscle t... Why this happens Both medications can independently cause muscle toxicity (myopathy). Furthermore,.

Patient information leaflet
Muskelsvaghet
This leaflet looks at types of muscle weakness and discusses the wide range of problems which can cause them. Muskelsvaghet is a common complaint but the word weakness can mean different things to different people - including tiredness, reduced power and failure to work at all. Muscle 'fatiga... This often goes along with muscle tiredness but is.

Patient information leaflet
Kan jag ta Bisoprolol och Simvastatin tillsammans?
There is no direct interaction between bisoprolol and simvastatin. However, both medications can occasionally cause muscle-related side effects, såsom weakness or fatigue. While... Why this happens Bisoprolol is a beta-blocker used for heart rate and blood pressure, while simvastatin is a statin used for cholesterol. Grapefruit contains a.

Patient information leaflet
Kan jag ta Atorvastatin och Tamsulosin tillsammans?
There is no known direct interaction between atorvastatin and tamsulosin. Why this happens Atorvastatin and tamsulosin are processed by different pathways in the body and do not interfere with how the other drug works or is cl... Muscle disorders - atorvastatin Seek immediate medical advice if you experience unexplained muscle pain, tenderness, or.
Vidare läsning och referenser
- Myostatin-related muscle hypertrophy; MedlinePlus, National Library of Medicine.
- Carnac G, Ricaud S, Vernus B, Bonnieu A. Myostatin: biology and clinical relevance. Mini Rev Med Chem. 2006 Jul;6(7):765-70. doi: 10.2174/138955706777698642.
- Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJ. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med. 2004 Jun 24;350(26):2682-8. doi: 10.1056/NEJMoa040933. No abstract available.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
2 Oct 2024 | Senaste versionen
1 Dec 2008 | Ursprungligen publicerad
Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.

